Ligand-targeted liposomal anticancer drugs
- 4 June 2003
- journal article
- review article
- Published by Elsevier in Progress in Lipid Research
- Vol. 42 (5) , 439-462
- https://doi.org/10.1016/s0163-7827(03)00032-8
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- By-passing of P-glycoprotein Using ImmunoliposomesJournal of Drug Targeting, 2002
- Selection of tumor-specific internalizing human antibodies from phage librariesJournal of Molecular Biology, 2000
- Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma modelInternational Journal of Cancer, 1999
- pH-Induced destabilization of lipid bilayers by a lipopeptide derived from influenza hemagglutininBiochimica et Biophysica Acta (BBA) - Biomembranes, 1997
- Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic DrugsCancer Biotherapy & Radiopharmaceuticals, 1997
- Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface‐grafted poly(ethylene glycol)FEBS Letters, 1996
- Peptide-Mediated Release of Folate-Targeted Liposome Contents from Endosomal Compartments1Journal of the American Chemical Society, 1996
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996
- Large unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Letters, 1987
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965